Cresset Asset Management, LLC Novo Cure LTD Transaction History
Cresset Asset Management, LLC
- $20.6 Billion
- Q1 2024
A detailed history of Cresset Asset Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cresset Asset Management, LLC holds 39,049 shares of NVCR stock, worth $737,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,049
Previous 20,039
94.87%
Holding current value
$737,245
Previous $299,000
104.01%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
280Shares Held
73MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$172 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$167 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$63.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$44.9 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.98B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...